Delivery Order SPE2DB20D1109-SPE2DB24FP84S

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,383.49, is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4557841419 EMVERM 100 MG TABLET CHEW UDS. The $3,546.70 firm fixed price Delivery Order has a completion date of July 20, 2022 and was awarded on July 19, 2022. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp is a Firm Fixed Price Delivery Order worth $2,183.96 to provide 4557842219 - EMVERM 100 MG TABLET CHEW UDS to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 20, 2022 and was awarded on July 19, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The award is a Delivery Order contract valued at $9,077.19 with a Firm Fixed Price pricing type. The contract is for the supply of EMVERM 100 MG TABLET CHEW UDS pharmaceutical products. This contract is not designated as a set-aside. Amerisourcebergen, as one of the largest pharmaceutical distributors in the U.S., leverages its extensive...
This federal contract award, valued at $1,872.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of EMVERM 100 MG TABLET CHEW UDS. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the specified pharmaceutical product to support military treatment facilities and federal...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,698.79 firm-fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product, with a period of performance through August 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $6,827.21. The contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS medication, and is a firm fixed-price contract with an ultimate completion date of June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors mentioned....
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ0ZY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,213.77 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. It is not a set-aside contract, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,736.21 firm fixed-price contract, with a completion date of March 25, 2025, is for the procurement of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,467.96 firm fixed-price contract has a completion date of February 4, 2025 and covers the supply of various pharmaceutical products and medical supplies to support federal healthcare programs, including those for the military and veterans. Amerisourcebergen holds a $999,999,999 Indefinite...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP84S
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $19,013.28 firm fixed price contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of September 5, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not mention any set-aside designation, indicating open competition.

Generated 2/27/25, 12:28 PM